2017
DOI: 10.1007/s00204-017-1972-3
|View full text |Cite
|
Sign up to set email alerts
|

On the necessity of translational cognitive-neurotoxicological research in methamphetamine abuse and addiction

Abstract: high-risk behaviors, treatment non-adherence, and repeated relapses. This ultimately contributes to maintaining continuous drug-seeking behaviors (Cadet and Bisagno 2015), and thus indirectly enhances all of the toxicological effects of METH abuse. METH is often consumed for its effects which, among others, include increased energy levels and decreases in fatigue, increased psychomotor activity and alertness, anorectic effects, increases in sex drive, and euphoria. Yet, irritability, agitation, risky sexual be… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 17 publications
(29 reference statements)
0
1
0
Order By: Relevance
“…There are evidence indicating that dopaminergic stimulation in the mesocorticolimbic system, especially in the nucleus accumbens, is responsible for methamphetamine and cocaine rewards phenomena (5). Methamphetamineinduced damage not only degenerates dopaminergic (DA) nerve terminals, but also reduces dopamine transporter (DAT) activity, tyrosine hydroxylase activity, and vesicular monoamine transporter-2 (VMAT) protein levels (6,7). Decreased concentrations of DA and DA metabolites have been shown in several brain regions of rodents or nonhuman primates following repeated administration of Copyright © 2021, Author(s).…”
Section: Introductionmentioning
confidence: 99%
“…There are evidence indicating that dopaminergic stimulation in the mesocorticolimbic system, especially in the nucleus accumbens, is responsible for methamphetamine and cocaine rewards phenomena (5). Methamphetamineinduced damage not only degenerates dopaminergic (DA) nerve terminals, but also reduces dopamine transporter (DAT) activity, tyrosine hydroxylase activity, and vesicular monoamine transporter-2 (VMAT) protein levels (6,7). Decreased concentrations of DA and DA metabolites have been shown in several brain regions of rodents or nonhuman primates following repeated administration of Copyright © 2021, Author(s).…”
Section: Introductionmentioning
confidence: 99%